Molecular pathways involved in the improvement of non-alcoholic fatty liver disease

Journal of Molecular Endocrinology

Volumn 51, Issue 1, 2013, Pages 167-179

  Paz Filho, Gilberto ^a   Mastronardi, Claudio Alberto ^a   Parker, Brian J ^a   Khan, Ainy ^a   Inserra, Antonio ^a   Matthaei, Klaus I ^a   Ehrhart Bornstein, Monika ^b   Bornstein, Stefan ^b   Wong, Ma Li ^a,c   Licinio, Julio ^a,c  

^a Biology and Environment   (Australia)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Adipose tissue; Leptin; Liver; Microarray

Indexed keywords

CARBOXYLIC ACID; CYTOCHROME P450; GA BINDING PROTEIN; GLUTATHIONE; HEME; INSULIN; IRON; LEPTIN; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHEROMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE; GLUTATHIONE METABOLISM; IMMUNITY; INFLAMMATION; INSULIN BLOOD LEVEL; LIVER INJURY; MALE; MICROARRAY ANALYSIS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; WILD TYPE;

ADIPOSE TISSUE; LEPTIN; LIVER; MICROARRAY;

ADIPOSE TISSUE, WHITE; ANIMALS; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HORMONES; INFLAMMATION MEDIATORS; INSULIN; LIVER; MALE; MICE; MICE, CONGENIC; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; STEROIDS;

EID: 84879990867     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0072     Document Type: Article

References (49)

1. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT et al. 2000 Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genetics 25 25-29. (doi:10.1038/75556)
2. Barros CC, Almeida SS, Mori MA, Valero VB, Haro AS, Batista EC, Rosa TS, Bacurau RF, Wurtele M & Araujo RC 2009 Efficient method for obtaining Lep(ob)/Lep(ob)-derived animal models using adipose tissue transplantations. International Journal of Obesity 33 938-944. (doi:10.1038/ijo.2009.95)
3. Benjamini Y & Hochberg Y 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B 57 289-300.
4. Brentani H, Caballero OL, Camargo AA, da Silva AM, da Silva WA Jr,Dias Neto E, Grivet M, Gruber A, Guimaraes PE, Hide W et al. 2003 The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. PNAS 100 13418-13423. (doi:10.1073/pnas.1233632100)
5. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN & Beretta L 2011 Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 6 e23937. (doi:10.1371/ journal.pone.0023937)
6. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M & Sanyal AJ 2012 The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 2005-2023. (doi:10.1002/hep.25762)
7. Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, Dillon JF, Ashford ML & Hayes JD 2010 Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radical Biology & Medicine 48 357-371. (doi:10.1016/j.freeradbiomed.2009.11.007)
8. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR & Grunfeld C 1999 Leptin deficiency enhances sensitivity to endotoxin-induced lethality. American Journal of Physiology 276 R136-R142.
9. Foster MT, Shi H, Softic S, Kohli R, Seeley RJ & Woods SC 2011 Transplantation of non-visceral fat to the visceral cavity improves glucose tolerance in mice: investigation of hepatic lipids and insulin sensitivity. Diabetologia 54 2890-2899. (doi:10.1007/ s00125-011-2259-5)
10. Fulton DL, Sundararajan S, Badis G, Hughes TR, Wasserman WW, Roach JC, Sladek R 2009 TFCat: the curated catalog of mouse and human transcription factors. Genome Biology 10 R29. (doi:10.1186/gb-2009- 10-3-r29)
11. Garg A & Misra A 2002 Hepatic steatosis, insulin resistance, and adipose tissue disorders. Journal of Clinical Endocrinology and Metabolism 87 3019-3022. (doi:10.1210/jc.87.7.3019)
12. Gonzalez M, Sealls W, Jesch ED, Brosnan MJ, Ladunga I, Ding X, Black PN & DiRusso CC 2011 Defining a relationship between dietary fatty acids and the cytochrome P450 system in a mouse model of fatty liver disease. Physiological Genomics 43 121-135. (doi:10.1152/physiolge-nomics.00209.2010)
13. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M et al. 2011 An HNF4a-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147 1233-1247. (doi:10.1016/j.cell. 2011.10.043)
14. Huang J, Tabbi-Anneni I, Gunda V & Wang L 2010 Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. American Journal of Physiology. Gastrointestinal and Liver Physiology 299 G1211-G1221. (doi:10.1152/ajpgi.00322.2010)
15. Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE & Gorden P 2005 Leptin reverses nonalcoholic steatohepa-titis in patients with severe lipodystrophy. Hepatology 41 753-760. (doi:10.1002/hep.20672)
16. Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E, Kawanaka M et al. 2012 Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 7 e38322. (doi:10.1371/journal.pone.0038322)
17. Klebanov S, Astle CM, DeSimone O, Ablamunits V & Harrison DE 2005 Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility. Journal of Endocrinology 186 203-211. (doi:10.1677/joe.1.06150)
18. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 1313-1321. (doi:10.1002/hep.20701)
19. Leclercq IA, Farrell GC, Schriemer R & Robertson GR 2002 Leptin is essential for the hepatic fibrogenic response to chronic liver injury. Journal of Hepatology 37 206-213. (doi:10.1016/S0168-8278(02)00102-2)
20. Leclercq IA, Vansteenberghe M, Lebrun VB, VanHul NK, Abarca-Quinones J, Sempoux CL, Picard C, Starkel P & Horsmans YL 2006 Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin. Laboratory Investigation 86 1161-1171.
21. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P & Mesirov JP 2011 Molecular signatures database (MSigDB) 3.0. Bioinformatics 27 1739-1740. (doi:10.1093/bioinformatics/btr260)
22. Luo W, Friedman MS, Shedden K, Hankenson KD & Woolf PJ 2009 GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10 161. (doi:10.1186/1471-2105-10-161)
23. Malhi H, Gores GJ & Lemasters JJ 2006 Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43 S31-S44. (doi:10.1002/hep.21062)
24. National Cancer Institute 2010 NCI-60 cell lines: Gene expression profiles from the NCI 60 data set downloaded from the Developmental Therapeutics Program web site (http://dtp.nci.nih.gov/mtargets/ download.html).
25. Neuschwander-Tetri BA & Caldwell SH 2003 Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 1202-1219. (doi:10.1053/jhep.2003.50193)
26. Pereira M Jr, Vidotti DB, Borra RC, Simoes Mde J, Da Silva ID & Haidar MA 2011 Involvement of GDF-9, leptin, and IGF1 receptors associated with adipose tissue transplantation on fertility restoration in obese anovulatory mice. Gynecological Endocrinology 27 759-766. (doi:10.3109/09513590.2010.534330)
27. Pessayre D 2007 Role of mitochondria in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 22 (Suppl 1) S20-S27. (doi:10.1111/j.1440-1746.2006.04640.x)
28. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP et al. 2001 Multiclass cancer diagnosis using tumor gene expression signatures. PNAS 98 15149-15154. (doi:10.1073/pnas.211566398)
29. Rosmarin AG, Resendes KK, Yang Z, McMillan JN & Fleming SL 2004 GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions. Blood Cells, Molecules & Diseases 32 143-154. (doi:10.1016/j.bcmd.2003. 09.005)
30. Rytka JM, Wueest S, Schoenle EJ & Konrad D 2011 The portal theory supported by venous drainage-selective fat transplantation. Diabetes 60 56-63. (doi:10.2337/db10-0697)
31. Sanyal AJ 2002 AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 1705-1725. (doi:10.1053/gast.2002.36572)
32. Sennello JA, Fayad R, Pini M, Gove ME & Fantuzzi G 2006 Transplantation of wild-type white adipose tissue normalizes metabolic, immune and inflammatory alterations in leptin-deficient ob/ob mice. Cytokine 36 261-266. (doi:10.1016/j.cyto.2007.02.001)
33. Sharma A, Bartell SM, Baile CA, Chen B, Podolsky RH, McIndoe RA & She JX 2010 Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice. PLoS ONE 5 e12147. (doi:10.1371/journal.pone.0012147)
34. Simha V, Subramanyam L, Szczepaniak L, Quittner C, Adams-Huet B, Snell P & Garg A 2012 Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety. Journal of Clinical Endocrinology and Metabolism 97 785-792. (doi:10.1210/jc.2011-2229)
35. Smyth GK 2005 Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor, 1 edn, pp 397-420. Eds R, Gentleman V, Carey S, Dudoit R Irizarry & W Huber. New York: Springer.
36. Stratowa C 2011 Package "xps" - Processing and Analysis of Affymetrix Oligonucleotide Arrays including Exon Arrays, Whole Genome Arrays and Plate Arrays. R package version 1.14.0. In: Bioconductor Software Packages 2011.
37. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson HF Jr et al. 2001 Molecular classification of human carcinomas by use of gene expression signatures. Cancer Research 61 7388-7393. (doi:10.1038/labinvest. 3700474)
38. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G et al. 2004 A gene atlas of the mouse and human protein-encoding transcriptomes. PNAS 101 6062-6067. (doi:10.1073/pnas.0400782101)
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102 15545-15550. (doi:10.1073/pnas.0506580102)
40. Tilg H & Moschen AR 2010 Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52 1836-1846. (doi:10.1002/hep.24001)
41. Tirindelli R, Dibattista M, Pifferi S & Menini A 2009 From pheromones to behavior. Physiological Reviews 89 921-956. (doi:10.1152/physrev. 00037.2008)
42. Tran TT, Yamamoto Y, Gesta S & Kahn CR 2008 Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metabolism 7 410-420. (doi:10.1016/j.cmet.2008.04.004)
43. Wang XW, Heegaard NH & Orum H 2012 MicroRNAs in liver disease. Gastroenterology 142 1431-1443. (doi:10.1053/j.gastro.2012.04.007)
44. Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A et al. 2007 IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 56 285-294. (doi:10.2337/db06-0436)
45. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ & Chan HL 2010 Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59 969-974. (doi:10.1136/gut.2009.205088)
46. 0 UTRs by comparison of several mammals. Nature 434 338-345. (doi:10.1038/nature03441)
47. Yanovski SZ & Yanovski JA 2011 Obesity prevalence in the United States - up, down, or sideways? New England Journal of Medicine 364 987-989. (doi:10.1056/NEJMp1009229)
48. Yilmaz Y 2012 Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Alimentary Pharmacology & Therapeutics 36 815-823. (doi:10.1111/j.1365-2036.2012.05196.x)
49. Zhang YK, Wu KC, Liu J & Klaassen CD 2012 Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicology and Applied Pharmacology 264 305-314. (doi:10.1016/j.taap.2012.09.014)